Skip to main content
OpenTrials

Clinical trial condition

Relapsed Pediatric ALL

Explore clinical trials studying Relapsed Pediatric ALL. Study availability and eligibility vary by location and protocol.

6 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Pediatric ALL trial results

Recruiting

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT05334823

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Beijing Children's Hospital.Capital Medical University Beijing, Beijing Municipality, China
  • Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China
  • Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View all 16 locations
View Trial Details
Recruiting

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

NCT03938987

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Foothills Medical Centre Calgary, Alberta, Canada
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View Trial Details

Related conditions